ZL-0516

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameZL-0516
Drug Alias NameZL-0516
ClassificationOther
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Texas Medical Branch
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A